drugset / Trial / NCT01103245

Aldosterone and the Metabolic Syndrome

NCT01103245

Phase 1 Completed 69 enrolled Vanderbilt University Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine the effects of mineralocorticoid receptor (MR) antagonism and renin inhibition on glucose metabolism in humans.

Timeline

Start
2010-03
Primary completion
2012-07
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aliskiren Small molecule 150 mg
Comparator Aliskiren Small molecule 300 mg
Comparator Spironolactone Small molecule 25 mg
Comparator Spironolactone Small molecule 50 mg
Comparator Hydrochlorothiazide Unknown 12.5 mg

Indications